These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8516434)

  • 1. [The pathology of mastopathy and breast cancer].
    Prechtel K
    Radiologe; 1993 May; 33(5):236-42. PubMed ID: 8516434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What is "mastopathy at risk" for the anatomopathologist?].
    Contesso G; Bertin F; Terrier P; Petit JY; Le M
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):9-12. PubMed ID: 2068489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mastopathy. Histological forms and long-term observations].
    Prechtel K
    Zentralbl Pathol; 1991; 137(3):210-9. PubMed ID: 1931894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists.
    Fitzgibbons PL; Henson DE; Hutter RV
    Arch Pathol Lab Med; 1998 Dec; 122(12):1053-5. PubMed ID: 9870852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histological typing of the breast by multifocal biopsies].
    Gary-Bobo A; Mateu J; Lamarque JL; Nevesny G; Pujol J
    Ann Chir Plast Esthet; 1992 Dec; 37(6):631-7. PubMed ID: 1340165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mastopathy and endometrial hyperplasia--coexistence, relationships].
    Teter J; Szamborski J
    Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):188-90. PubMed ID: 8084821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic immunohistochemistry of breast epithelial lesions].
    Balaton AJ; Guinebretière JM; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Locally and regionally limited breast cancer from the pathologist's view point].
    Gloor F
    Schweiz Med Wochenschr; 1977 Jul; 107(28):969-72. PubMed ID: 897635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast pathology practice: most common problems in a consultation service.
    Putti TC; Pinder SE; Elston CW; Lee AH; Ellis IO
    Histopathology; 2005 Nov; 47(5):445-57. PubMed ID: 16241992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic difficulties and limits in breast histopathology in core biopsies (breast microbiopsies)].
    Bellocq JP; Zafrani B; Chenard MP
    Arch Anat Cytol Pathol; 1998; 46(4):257-60. PubMed ID: 9754388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mastopathy associated with early breast cancer].
    Anazawa S; Ebina D; Sakamoto G; Sugano H; Hukami A; Kuno K
    Gan No Rinsho; 1985 May; Suppl():143-7. PubMed ID: 4068232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer risk in breast lesions: diagnostic and therapeutic strategy].
    Bove F; Bilancio G; De Falco M; Parmeggiani D; Sperlongano P; Barbarisi A; Parmeggiani U
    Minerva Chir; 2003 Jun; 58(3):375-83. PubMed ID: 12955059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on stromal component of mastopathy--content and type of collagen].
    Okano F
    Hokkaido Igaku Zasshi; 1985 Jul; 60(4):555-70. PubMed ID: 2997011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of ductal carcinoma in situ by the pathologist: current questions].
    Arnould L; Caron Y; Sigal-Zafrani B
    Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of non-palpable breast lesions with vacuum-assisted large core needle biopsies (Mammotome). Experience with 560 procedures at the Val d'Aurelle Center].
    Bibeau F; Chateau MC; Masson B
    Ann Pathol; 2003 Dec; 23(6):582-92. PubMed ID: 15094596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.